TOP｜ 特許｜ 意匠｜ 商標
商標ウォッチ Twitter
公開日2024-12-04
公報種別公開国際商標公報
国際登録番号1812649
国際登録日2024-08-23
区分第5類(薬剤),第42類(科学・技術)
商品役務Diagnostic biomarker reagents for medical and clinical purposes; biomarkers for use individually or in combination to detect tissue formation, tissue remodeling, or tissue destruction; biomarker assays to identify disease activity; biomarker assays to quantify disease activity; biomarker assays to analyse disease activity; diagnostic kits comprised of medical diagnostic reagents and assays for use in disease detection, disease analysis and quantifying disease activity; medical diagnostic agents; medical diagnostic reagents; clinical diagnostic agents; clinical diagnostic reagents; diagnostic preparations, substances and materials; medical diagnostic test strips; diagnostic preparations for medical purposes; diagnostic agents for medical use.,Design and development of blood-based biomarker assays to identify, quantify and analyse disease activity; design and development of diagnostic biomarker reagents for medical, pharmaceutical, and scientific purposes; design and development of biochemical, pharmaceutical, and medical assays; design and development of biomarkers for use individually or in combination to detect tissue formation, tissue remodeling, or tissue destruction; scientific and pharmaceutical research in the field of biomarkers and biomarker discovery; identification of predictive and prognostic biomarkers for clinical trials; identifing patients for clinical trials most likely to respond to a given treatment using biomarkers; laboratory services relating to clinical trials; clinical trials; analysis of pharmacodynamic data; analysis of data relating to biomarkers; development of diagnostic preparations, equipment and tests; clinical testing services; diagnostic testing services; testing services relating to the detection and measurement of biomarkers; testing samples for the presence of biomarkers; laboratory services; medical laboratory services; research laboratory services; medical, pre-clinical, clinical, biological, biotechnological and pharmaceutical research全 22 件を表示, experimentation, development, and analysis; advice, information and assistance relating to the foregoing.
基礎出願番号019002624
基礎出願日2024-03-21
基礎出願国EM
出願人Nordic Bioscience A/S
OCRテキストnordicEndotrophin
OCRテキスト2nordicEndotrophin
OCRについて
この商標をJ-PlatPatで参照する

関連商標

Precision Hydration Limited
PRECISIONFUEL&HYDRATION
3日前
GlaxoSmithKline Biologicals S.A.
EXFLUNA
1か月前
GlaxoSmithKline Biologicals S.A.
RIXFLUGO
1か月前
GlaxoSmithKline Biologicals S.A.
FLUVIXVY
10日前
GlaxoSmithKline Biologicals S.A.
FLUVIXGO
10日前
Merck Sharp & Dohme B.V.
17日前
Merck Sharp & Dohme B.V.
17日前
Merck Sharp & Dohme B.V.
17日前
Merck Sharp & Dohme B.V.
17日前
Bayer Aktiengesellschaft
AUMBEYA
17日前
iOnctura SA
17日前
Gilead Sciences Ireland UC
17日前
Merck Sharp & Dohme B.V.
17日前
Merck Sharp & Dohme B.V.
17日前
Merck Sharp & Dohme B.V.
17日前
Zym Ice ehf.
UNBROKEN
17日前
Gilead Sciences Ireland UC
17日前
Shenzhen Wandao Cell Technology Co., Ltd.
WonderCel THERAPEUTICS
2か月前
NewTree Co., Ltd.
마스터바이옴 masterbiom
17日前
SMILEAT S.L.
SMILEAT
17日前
CooperSurgical, Inc.
ViaBL
17日前
Omeros Corporation
17日前
Trogenix Ltd
TGX
17日前
Trogenix Ltd
TROGENIX
17日前
Merck Sharp & Dohme B.V.
UPCINTO
17日前
Merck Sharp & Dohme B.V.
VIXCORLO
17日前
Merck Sharp & Dohme B.V.
BEATORZO
17日前
Boehringer Ingelheim International GmbH
17日前
Merck Sharp & Dohme B.V.
UNEQSI
17日前
Merck Sharp & Dohme B.V.
INTYVRIQ
17日前
Merck Sharp & Dohme B.V.
SECORZIO
17日前
Gilead Sciences Ireland UC
17日前
Gilead Sciences Ireland UC
17日前
Gilead Sciences Ireland UC
17日前
Zenas BioPharma (USA) LLC
ZENASBIOPHARMA
24日前
BIOPTIMIZERS USA, INC.
24日前
続きを見る